Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_49303 | 64 | 1.33 | Mlig455_058897 | Neo: - Age: - |
SALL3 | Mlig455_058897 {REF} {Length: 4598} {Pfam: Zinc finger, C2H2 type [PF00096.28, score=70.9]; C2H2-type zinc finger [PF13894.8, score=55.8]; Zinc-finger double domain [PF13465.8, score=55.4]; Zinc-finger of C2H2 type [PF12874.9, score=45.8]; Zinc-finger double-stranded RNA-binding [PF12171.10, score=39.1]} {Human: ENSG00000256463, SALL3, spalt like transcription factor 3, [Score=92.4, Expect=3e-18]; ENSG00000277015, SALL3, spalt like transcription factor 3, [Score=92.4, Expect=3e-18]; ENSG00000263310, SALL3, spalt like transcription factor 3, [Score=92.4, Expect=3e-18]; ENSG00000101115, SALL4, spalt like transcription factor 4, [Score=91.3, Expect=5e-18]; ENSG00000130856, ZNF236, zinc finger protein 236, [Score=90.9, Expect=1e-17]; ENSG00000103449, SALL1, spalt like transcription factor 1, [Score=90.1, Expect=2e-17]} {Mouse: ENSMUSG00000024565, Sall3, spalt like transcription factor 3, [Score=92.0, Expect=2e-18]; ENSMUSG00000027547, Sall4, spalt like transcription factor 4, [Score=91.7, Expect=3e-18]; ENSMUSG00000031665, Sall1, spalt like transcription factor 1, [Score=90.1, Expect=1e-17]} {Dmel: FBgn0261648, salm, spalt major, [RH, Score=97.4, Expect=5e-20]} {Celegans: WBGene00004773, sem-4, SEM-4 long form, [RH, Score=97.4, Expect=2e-20]} {Smed: dd_Smed_v6_14176_0_1, dd_Smed_v6_14176_0_1, [RH, Score=121, Expect=2e-28]} {RNA1310_43057} {RNA815_29425} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -2.449 | 1.318 | 1.00000 | 1.00000 | |
RegionR2 | 2.252 | 1.318 | 0.28031 | 0.66702 | |
RegionR3 | -0.689 | 1.318 | 0.90532 | 1.00000 | |
RegionR4 | 0.624 | 1.318 | 0.59312 | 0.90735 | |
RegionR5 | 0.614 | 1.318 | 0.57103 | 0.92989 | |
RegionR6 | 1.995 | 1.318 | 0.22466 | 0.80654 | |
RegionR7 | -3.63 | 1.318 | 1.00000 | 1.00000 | |
RegionR8 | 1.284 | 1.318 | 0.49604 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | 0.328 | 1.318 | 0.99998 | 1.00000 | |
RegenerationR2 | 1.01 | 1.318 | 0.41687 | 0.82524 | |
RegenerationR3 | -1.013 | 1.318 | 0.50061 | 0.85734 | |
RegenerationR4 | -1.085 | 1.318 | 0.49422 | 0.86695 | |
RegenerationR5 | -3.334 | 1.318 | 0.03472 | 0.31045 | |
RegenerationR6 | 0.392 | 1.318 | 0.73785 | 0.94595 | |
RegenerationBL | 2.338 | 1.318 | 0.20693 | 0.54929 | |
RegenerationTP | -1.973 | 1.318 | 0.99973 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_49303 | 64 | 1.33 | Mlig455_058897 | Neo: - Age: - |
SALL3 | 5 | 1.000 | 1.000 | 1.000 | - | 1.000 | 1.000 | Mlig455_058897 {REF} {Length: 4598} {Pfam: Zinc finger, C2H2 type [PF00096.28, score=70.9]; C2H2-type zinc finger [PF13894.8, score=55.8]; Zinc-finger double domain [PF13465.8, score=55.4]; Zinc-finger of C2H2 type [PF12874.9, score=45.8]; Zinc-finger double-stranded RNA-binding [PF12171.10, score=39.1]} {Human: ENSG00000256463, SALL3, spalt like transcription factor 3, [Score=92.4, Expect=3e-18]; ENSG00000277015, SALL3, spalt like transcription factor 3, [Score=92.4, Expect=3e-18]; ENSG00000263310, SALL3, spalt like transcription factor 3, [Score=92.4, Expect=3e-18]; ENSG00000101115, SALL4, spalt like transcription factor 4, [Score=91.3, Expect=5e-18]; ENSG00000130856, ZNF236, zinc finger protein 236, [Score=90.9, Expect=1e-17]; ENSG00000103449, SALL1, spalt like transcription factor 1, [Score=90.1, Expect=2e-17]} {Mouse: ENSMUSG00000024565, Sall3, spalt like transcription factor 3, [Score=92.0, Expect=2e-18]; ENSMUSG00000027547, Sall4, spalt like transcription factor 4, [Score=91.7, Expect=3e-18]; ENSMUSG00000031665, Sall1, spalt like transcription factor 1, [Score=90.1, Expect=1e-17]} {Dmel: FBgn0261648, salm, spalt major, [RH, Score=97.4, Expect=5e-20]} {Celegans: WBGene00004773, sem-4, SEM-4 long form, [RH, Score=97.4, Expect=2e-20]} {Smed: dd_Smed_v6_14176_0_1, dd_Smed_v6_14176_0_1, [RH, Score=121, Expect=2e-28]} {RNA1310_43057} {RNA815_29425} |
2. | MligTC455_15884 | 26 | 0.54 | Mlig455_066451 | Neo: - Age: - Region-enriched R2: 9.632/0.00394 |
1.8 | - | 0.967 | 0.833 | - | - | - | Mlig455_066451 {REF} {Length: 1468} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=20.9]} {RNA1310_27849} {RNA815_37376} | |
3. | MligTC455_08763 | 20 | 0.41 | Mlig455_061186 | Neo: - Age: - |
1.778 | - | 0.977 | 0.801 | - | - | - | Mlig455_061186 {REF} {Length: 1077} {Smed: dd_Smed_v6_13791_0_1, dd_Smed_v6_13791_0_1, [Score=96.3, Expect=3e-24]} {RNA1310_122132} | |
4. | MligTC455_50541 | 82 | 1.71 | Mlig455_010939 | Neo: - Age: Down-Down-Up |
NFIA | 1.749 | - | - | 0.776 | - | 0.973 | - | Mlig455_010939 {REF} {Length: 3569} {Human: ENSG00000162599, NFIA, nuclear factor I A, [Score=85.1, Expect=1e-16]; ENSG00000147862, NFIB, nuclear factor I B, [Score=84.3, Expect=2e-16]; ENSG00000008441, NFIX, nuclear factor I X, [Score=82.4, Expect=7e-16]; ENSG00000141905, NFIC, nuclear factor I C, [Score=81.6, Expect=1e-15]} {Mouse: ENSMUSG00000028565, Nfia, nuclear factor I/A, [Score=84.7, Expect=9e-17]; ENSMUSG00000008575, Nfib, nuclear factor I/B, [Score=84.3, Expect=1e-16]; ENSMUSG00000055053, Nfic, nuclear factor I/C, [Score=83.2, Expect=2e-16]; ENSMUSG00000001911, Nfix, nuclear factor I/X, [Score=81.6, Expect=9e-16]} {Dmel: FBgn0042696, NfI, Nuclear factor I, [Score=84.7, Expect=1e-16]} {Celegans: WBGene00003592, nfi-1, NFI (Nuclear Factor I) family, [Score=90.9, Expect=1e-18]} {Smed: dd_Smed_v6_12312_0_1, dd_Smed_v6_12312_0_1, [Score=151, Expect=8e-38]} {RNA1310_40008.1} {RNA815_37863} |
5. | MligTC455_47927 | 43 | 0.9 | Mlig455_029720 | Neo: - Age: - |
1.725 | 0.748 | 0.977 | - | - | - | - | Mlig455_029720 {REF} {Length: 2459} {RNA1509_35671} {RNA1310_75812} {RNA815_33002} | |
6. | MligTC455_09874 | 31 | 0.65 | Mlig455_045071 | Neo: - Age: - |
DOC2A | 1.701 | - | 0.977 | 0.724 | - | - | - | Mlig455_045071 {REF} {Length: 1760} {Pfam: C2 domain [PF00168.32, score=55.9]} {Human: ENSG00000149927, DOC2A, double C2 domain alpha, [Score=55.8, Expect=7e-08]} {Mouse: ENSMUSG00000052301, Doc2a, double C2, alpha, [Score=55.5, Expect=7e-08]} {Celegans: WBGene00004923, snt-3, SyNapTotagmin, [Score=70.5, Expect=2e-13]} {Smed: dd_Smed_v6_16731_0_1, dd_Smed_v6_16731_0_1, [Score=112, Expect=7e-27]} {RNA1310_36283} {RNA815_40844} |
7. | MligTC455_16248 | 132 | 2.74 | Mlig455_038325, Mlig455_050222, Mlig455_050231 | Neo: - Age: - |
CHRNA3 | 1.681 | - | 0.977 | 0.704 | - | - | - | Mlig455_038325 {REF} {Length: 1078} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=200.0]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=192, Expect=4e-57]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=194, Expect=7e-58]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=190, Expect=1e-56]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=206, Expect=1e-62]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=186, Expect=4e-55]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=216, Expect=5e-67]} {RNA1310_44575} {RNA815_22042} Mlig455_050222 {REF} {Length: 2164} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=202.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=197.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=348, Expect=5e-114]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=335, Expect=4e-109]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=348, Expect=2e-114]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=343, Expect=2e-112]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=335, Expect=5e-109]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=397, Expect=1e-133]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=338, Expect=2e-110]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=489, Expect=5e-170]} {RNA1310_44575} {RNA815_22042} Mlig455_050231 {REF} {Length: 2219} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=203.3]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=143.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=304, Expect=5e-99]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=299, Expect=8e-97]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=293, Expect=2e-94]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=290, Expect=7e-92]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=302, Expect=3e-98]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=296, Expect=3e-96]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=291, Expect=5e-94]} {Dmel: FBgn0000036, nAChRalpha1, nicotinic Acetylcholine Receptor alpha1, [Score=352, Expect=8e-117]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=303, Expect=5e-99]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=424, Expect=2e-146]} {RNA1310_44575} {RNA815_22042} |
8. | MligTC455_47197 | 155 | 3.24 | Mlig455_049096, Mlig455_049118 | Neo: - Age: - |
1.678 | - | 0.953 | - | - | - | 0.725 | Mlig455_049096 {REF} {Length: 3209} {Smed: dd_Smed_v6_14861_0_1, dd_Smed_v6_14861_0_1, [Score=151, Expect=1e-37]} {RNA1509_52343} {RNA1310_44918.1} {RNA815_41725} Mlig455_049118 {REF} {Length: 3116} {Smed: dd_Smed_v6_14861_0_1, dd_Smed_v6_14861_0_1, [Score=160, Expect=1e-40]} {RNA1509_52343} {RNA1310_44918.1} {RNA815_41725} |
|
9. | MligTC455_25242 | 55 | 1.15 | Mlig455_046799, Mlig455_063518 | Neo: - Age: - Region-enriched R2: 5.810/0.00185 |
DOC2B, RPH3A | 1.669 | - | 0.951 | 0.718 | - | - | - | Mlig455_046799 {REF} {Length: 1832} {Pfam: C2 domain [PF00168.32, score=147.1]} {Human: ENSG00000272636, DOC2B, double C2 domain beta, [Score=243, Expect=3e-76]; ENSG00000272670, DOC2B, double C2 domain beta, [Score=243, Expect=3e-76]; ENSG00000089169, RPH3A, rabphilin 3A, [Score=237, Expect=3e-71]; ENSG00000149927, DOC2A, double C2 domain alpha, [Score=234, Expect=1e-72]} {Mouse: ENSMUSG00000020848, Doc2b, double C2, beta, [Score=243, Expect=3e-76]; ENSMUSG00000052301, Doc2a, double C2, alpha, [Score=239, Expect=1e-74]; ENSMUSG00000029608, Rph3a, rabphilin 3A, [Score=237, Expect=4e-71]} {Dmel: FBgn0030230, Rph, Rabphilin, [RH, Score=188, Expect=2e-55]} {Celegans: WBGene00004316, rbf-1, Rabphilin-1, [Score=216, Expect=4e-62]} {Smed: dd_Smed_v6_12977_0_1, dd_Smed_v6_12977_0_1, [Score=239, Expect=5e-73]} {RNA1310_26201} {RNA815_12702} Mlig455_063518 {REF} {Length: 2724} {Pfam: C2 domain [PF00168.32, score=147.7]} {Human: ENSG00000089169, RPH3A, rabphilin 3A, [RH, Score=240, Expect=2e-72]} {Mouse: ENSMUSG00000029608, Rph3a, rabphilin 3A, [RH, Score=240, Expect=2e-72]} {Dmel: FBgn0030230, Rph, Rabphilin, [RH, Score=191, Expect=1e-54]} {Celegans: WBGene00004316, rbf-1, Rabphilin-1, [Score=219, Expect=4e-63]} {Smed: dd_Smed_v6_12977_0_2, dd_Smed_v6_12977_0_2, [Score=241, Expect=1e-73]} {RNA1310_26201} {RNA815_12702} |
10. | MligTC455_57312 | 3 | 0.06 | Mlig455_043531 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_043531 {REF} {Length: 430} {Pfam: Leucine rich repeat N-terminal domain [PF01462.20, score=32.6]} | |
11. | MligTC455_55389 | 7 | 0.14 | Mlig455_051098 | Neo: - Age: - |
0.995 | - | - | - | - | 0.995 | - | Mlig455_051098 {REF} {Length: 79} {NoTransDecoderORF} {RNA1310_22135} | |
12. | MligTC455_17323 | 15 | 0.32 | Mlig455_012298 | Neo: Int S/G2/M Age: - |
0.992 | - | - | - | - | 0.992 | - | Mlig455_012298 {REF} {Length: 2351} {RNA1310_93397} {RNA815_47617} | |
13. | MligTC455_30852 | 46 | 0.96 | Mlig455_019345, Mlig455_019563, Mlig455_059135 | Neo: - Age: - |
GRIA2, GRIK2, GRIK4 | 0.992 | - | - | - | - | 0.992 | - | Mlig455_019345 {REF} {Length: 3399} {Pfam: Ligand-gated ion channel [PF00060.28, score=95.4]; Receptor family ligand binding region [PF01094.30, score=56.8]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=44.5]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=25.8]; Iron-containing alcohol dehydrogenase [PF13685.8, score=21.9]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=159, Expect=1e-39]; ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=157, Expect=9e-39]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=159, Expect=7e-40]; ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=155, Expect=2e-38]} {Dmel: FBgn0039927, CG11155, [Score=160, Expect=3e-40]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=126, Expect=1e-29]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [RH, Score=281, Expect=4e-87]} {RNA1509_10728} {RNA1310_122.1} {RNA815_8415.1} Mlig455_019563 {REF} {Length: 2692} {Pfam: Ligand-gated ion channel [PF00060.28, score=91.5]} {Human: ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=98.6, Expect=6e-23]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=95.9, Expect=5e-22]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=94.7, Expect=1e-21]} {Mouse: ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=96.7, Expect=2e-22]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=95.9, Expect=3e-22]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=94.7, Expect=9e-22]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=92.8, Expect=4e-21]} {Dmel: FBgn0038837, CG3822, [Score=99.4, Expect=2e-23]} {Celegans: WBGene00001615, glr-4, GLutamate Receptor family (AMPA), [Score=92.8, Expect=2e-21]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=176, Expect=4e-53]} {RNA1310_21734.1} {RNA815_52393} Mlig455_059135 {REF} {Length: 3434} {Pfam: Receptor family ligand binding region [PF01094.30, score=58.7]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=45.1]; Iron-containing alcohol dehydrogenase [PF13685.8, score=23.1]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=71.6, Expect=2e-12]} {Mouse: ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=70.5, Expect=3e-12]} {Dmel: FBgn0038837, CG3822, [Score=62.0, Expect=1e-09]} {Celegans: WBGene00001617, glr-6, GLutamate Receptor family (AMPA), [Score=68.6, Expect=6e-12]} {Smed: dd_Smed_v6_41723_0_2, dd_Smed_v6_41723_0_2, [Score=85.1, Expect=8e-18]} {RNA1509_10728} {RNA1310_122.1} {RNA815_8415.1} |
14. | MligTC455_16785 | 99 | 2.06 | Mlig455_061289, Mlig455_061323, Mlig455_062675 | Neo: - Age: - |
0.989 | - | - | - | - | 0.989 | - | Mlig455_061289 {REF} {Length: 2624} {RNA1509_55425} {RNA1310_21283, RNA1509_55425} {RNA1509_55425, RNA815_20966} Mlig455_061323 {REF} {Length: 2546} {RNA1509_55425} {RNA1310_21283} {RNA815_20966} Mlig455_062675 {REF} {Length: 2625} {RNA1509_55425} {RNA1310_21283} {RNA815_20966} |
|
15. | MligTC455_02837 | 29 | 0.61 | Mlig455_004700 | Neo: - Age: - Region-enriched R6: 6.687/0.01418 |
0.988 | - | - | - | - | 0.988 | - | Mlig455_004700 {REF} {Length: 1630} {RNA1509_44223} {RNA1310_194.1} {RNA815_27158} | |
16. | MligTC455_09304 | 155 | 3.23 | Mlig455_065453 | Neo: - Age: Down-Up-Down Region-enriched R4: 3.745/0.02737 |
0.985 | - | - | - | - | 0.985 | - | Mlig455_065453 {REF} {Length: 2759} {TRANSSPLICED} {RNA1509_35599} {RNA1310_29110} {RNA815_21725} | |
17. | MligTC455_43491 | 87 | 1.81 | Mlig455_060858 | Neo: - Age: - Region-enriched R5: 1.917/0.03567 |
0.985 | - | - | 0.985 | - | - | - | Mlig455_060858 {REF} {Length: 1176} {RNA1310_53969} {RNA815_18026} | |
18. | MligTC455_30595 | 5 | 0.11 | Mlig455_052242 | Neo: - Age: - |
0.984 | - | - | - | - | 0.984 | - | Mlig455_052242 {REF} {Length: 2223} {Pfam: Mab-21 protein [PF03281.16, score=19.5]} {RNA1509_39688} {RNA1310_6142.1} {RNA815_6750.1} | |
19. | MligTC455_11983 | 31 | 0.65 | Mlig455_018799, Mlig455_018971 | Neo: - Age: - |
0.982 | - | - | - | - | 0.982 | - | Mlig455_018799 {REF} {Length: 1330} {TRANSSPLICED} {Smed: dd_Smed_v6_1404_0_1, dd_Smed_v6_1404_0_1, [Score=79.7, Expect=4e-16]} Mlig455_018971 {REF} {Length: 1242} {Smed: dd_Smed_v6_1404_0_1, dd_Smed_v6_1404_0_1, [Score=77.4, Expect=2e-15]} |
|
20. | MligTC455_08211 | 5 | 0.09 | Mlig455_038301 | Neo: - Age: - |
0.981 | - | - | - | - | 0.981 | - | Mlig455_038301 {REF} {Length: 512} {NoTransDecoderORF} | |
21. | MligTC455_16342 | 20 | 0.42 | Mlig455_012507 | Neo: - Age: - |
0.981 | - | 0.981 | - | - | - | - | Mlig455_012507 {REF} {Length: 1825} {Pfam: Calcium-activated potassium channel, beta subunit [PF03185.17, score=61.0]} {Smed: dd_Smed_v6_14020_0_1, dd_Smed_v6_14020_0_1, [RH, Score=132, Expect=2e-38]} {RNA1509_23873} {RNA1310_73480} {RNA815_38079} | |
22. | MligTC455_17370 | 13 | 0.27 | Mlig455_014235 | Neo: - Age: - |
0.981 | - | - | - | - | 0.981 | - | Mlig455_014235 {REF} {Length: 465} {NoTransDecoderORF} {RNA1310_77462} | |
23. | MligTC455_27751 | 8 | 0.16 | Mlig455_006257 | Neo: - Age: Up-Down-Up |
ALKBH3 | 0.981 | - | - | - | - | 0.981 | - | Mlig455_006257 {REF} {Length: 2864} {Pfam: 2OG-Fe(II) oxygenase superfamily [PF13532.8, score=76.9]} {Human: ENSG00000166199, ALKBH3, alkB homolog 3, alpha-ketoglutaratedependent dioxygenase, [Score=108, Expect=3e-25]} {Mouse: ENSMUSG00000040174, Alkbh3, alkB homolog 3, alpha-ketoglutarate-dependent dioxygenase, [Score=101, Expect=5e-23]} {Smed: dd_Smed_v6_7441_0_1, dd_Smed_v6_7441_0_1, [Score=81.6, Expect=1e-16]} {RNA1509_23004} {RNA1310_19653} {RNA815_20132} |
24. | MligTC455_12116 | 106 | 2.2 | Mlig455_004661, Mlig455_004728 | Neo: - Age: Up-Up-Down |
0.979 | - | 0.979 | - | - | - | - | Mlig455_004661 {REF} {Length: 3441} {RNA1509_48407} {RNA1310_2938.1} {RNA815_14343.2} Mlig455_004728 {REF} {Length: 2670} {RNA1509_48407} {RNA1310_45267.1, RNA1509_48407} {RNA1509_48407, RNA815_58661} |
|
25. | MligTC455_24270 | 71 | 1.47 | Mlig455_005120 | Neo: - Age: - |
CHRNA7 | 0.979 | - | 0.979 | - | - | - | - | Mlig455_005120 {REF} {Length: 1530} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=115.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=66.6]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=148, Expect=4e-39]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=147, Expect=5e-39]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=145, Expect=4e-38]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=146, Expect=2e-38]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=140, Expect=1e-36]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=135, Expect=5e-34]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=134, Expect=9e-35]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=133, Expect=4e-34]} {RNA1509_43533} {RNA1310_20839.2} {RNA815_22406} |
26. | MligTC455_52926 | 9 | 0.18 | Mlig455_024897 | Neo: - Age: - |
0.979 | - | 0.979 | - | - | - | - | Mlig455_024897 {REF} {Length: 428} {NoTransDecoderORF} {RNA1310_119495} | |
27. | MligTC455_36567 | 18 | 0.37 | Mlig455_065030 | Neo: - Age: - |
0.978 | - | 0.978 | - | - | - | - | Mlig455_065030 {REF} {Length: 672} | |
28. | MligTC455_08098 | 15 | 0.31 | Mlig455_029099 | Neo: - Age: - Region-enriched R2: 8.013/0.00338 |
0.977 | - | 0.977 | - | - | - | - | Mlig455_029099 {REF} {Length: 1334} {RNA1310_58776} {RNA815_46110} | |
29. | MligTC455_08408 | 41 | 0.86 | Mlig455_043171 | Neo: - Age: Up-Down-Down |
0.977 | - | 0.977 | - | - | - | - | Mlig455_043171 {REF} {Length: 1568} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=19.4]} {RNA1310_47844} {RNA815_49360} | |
30. | MligTC455_10229 | 24 | 0.49 | Mlig455_023615 | Neo: - Age: - |
0.977 | - | 0.977 | - | - | - | - | Mlig455_023615 {REF} {Length: 1635} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=22.2]} {RNA1310_22533.3} {RNA815_23050} | |
31. | MligTC455_10810 | 6 | 0.12 | Mlig455_069505 | Neo: - Age: - |
0.977 | - | 0.977 | - | - | - | - | Mlig455_069505 {REF} {Length: 376} {NoTransDecoderORF} {RNA1310_40761} | |
32. | MligTC455_11661 | 4 | 0.08 | Mlig455_019371, Mlig455_059103 | Neo: - Age: - |
0.977 | - | 0.977 | - | - | - | - | Mlig455_019371 {REF} {Length: 67} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_39490} {RNA1310_101865} {RNA815_41733} Mlig455_059103 {REF} {Length: 67} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_39490} {RNA1310_101865} {RNA815_41733} |
|
33. | MligTC455_12978 | 63 | 1.31 | Mlig455_023948 | Neo: - Age: - |
0.977 | - | 0.977 | - | - | - | - | Mlig455_023948 {REF} {Length: 2929} {RNA1310_80095.1} | |
34. | MligTC455_13049 | 53 | 1.11 | Mlig455_029230, Mlig455_029252, Mlig455_035639, Mlig455_035735 | Neo: - Age: Down-Up-Down Region-enriched R2: 6.077/0.00215 |
HTR2A | 0.977 | - | 0.977 | - | - | - | - | Mlig455_029230 {REF} {Length: 2756} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=149.9]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=46.0]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=25.6]; Unstructured region C-term to UIM in Ataxin3 [PF16619.7, score=24.1]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=19.2]} {Human: ENSG00000102468, HTR2A, 5-hydroxytryptamine receptor 2A, [Score=142, Expect=3e-37]} {Mouse: ENSMUSG00000034997, Htr2a, 5-hydroxytryptamine (serotonin) receptor 2A, [Score=141, Expect=5e-37]; ENSMUSG00000041380, Htr2c, 5-hydroxytryptamine (serotonin) receptor 2C, [Score=138, Expect=8e-36]} {Dmel: FBgn0261929, 5-HT2B, 5-hydroxytryptamine (serotonin) receptor 2B, [Score=131, Expect=1e-32]} {Celegans: WBGene00004776, ser-1, SERotonin/octopamine receptor family; Serotonin receptor, [Score=120, Expect=2e-29]} {Smed: dd_Smed_v6_24518_0_1, dd_Smed_v6_24518_0_1, [RH, Score=281, Expect=8e-90]} {RNA1310_91864} Mlig455_029252 {REF} {Length: 2844} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=188.6]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=43.8]; Spt20 family [PF12090.10, score=21.4]} {Human: ENSG00000102468, HTR2A, 5-hydroxytryptamine receptor 2A, [Score=144, Expect=2e-36]} {Mouse: ENSMUSG00000034997, Htr2a, 5-hydroxytryptamine (serotonin) receptor 2A, [Score=142, Expect=4e-36]; ENSMUSG00000041380, Htr2c, 5-hydroxytryptamine (serotonin) receptor 2C, [Score=140, Expect=1e-35]} {Dmel: FBgn0004514, Oct-TyrR, Octopamine-Tyramine receptor, [Score=136, Expect=2e-33]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=157, Expect=2e-41]} {Smed: dd_Smed_v6_24518_0_1, dd_Smed_v6_24518_0_1, [RH, Score=336, Expect=4e-108]} {RNA1310_91864} Mlig455_035639 {REF} {Length: 2811} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=182.5]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=43.7]; Spt20 family [PF12090.10, score=24.8]} {Human: ENSG00000102468, HTR2A, 5-hydroxytryptamine receptor 2A, [Score=144, Expect=2e-36]} {Mouse: ENSMUSG00000034997, Htr2a, 5-hydroxytryptamine (serotonin) receptor 2A, [Score=143, Expect=3e-36]; ENSMUSG00000041380, Htr2c, 5-hydroxytryptamine (serotonin) receptor 2C, [Score=141, Expect=1e-35]} {Dmel: FBgn0261929, 5-HT2B, 5-hydroxytryptamine (serotonin) receptor 2B, [Score=133, Expect=6e-32]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=156, Expect=5e-41]} {Smed: dd_Smed_v6_24518_0_1, dd_Smed_v6_24518_0_1, [RH, Score=284, Expect=3e-88]} {RNA1310_91864} Mlig455_035735 {REF} {Length: 1469} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=140.9]; Spt20 family [PF12090.10, score=23.0]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=18.8]} {Human: ENSG00000102468, HTR2A, 5-hydroxytryptamine receptor 2A, [Score=97.1, Expect=3e-21]; ENSG00000147246, HTR2C, 5-hydroxytryptamine receptor 2C, [Score=95.1, Expect=2e-20]} {Mouse: ENSMUSG00000034997, Htr2a, 5-hydroxytryptamine (serotonin) receptor 2A, [Score=95.5, Expect=1e-20]; ENSMUSG00000041380, Htr2c, 5-hydroxytryptamine (serotonin) receptor 2C, [Score=93.2, Expect=6e-20]} {Dmel: FBgn0261929, 5-HT2B, 5-hydroxytryptamine (serotonin) receptor 2B, [Score=89.0, Expect=2e-18]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=115, Expect=1e-27]} {Smed: dd_Smed_v6_31134_0_1, dd_Smed_v6_31134_0_1, [Score=249, Expect=4e-77]} {RNA1310_91864} |
35. | MligTC455_18139 | 70 | 1.45 | Mlig455_010809 | Neo: - Age: logFC(26M/2M)=-0.809 Region-enriched R2: 6.868/0.00081 |
TRPC5 | 0.977 | - | 0.977 | - | - | - | - | Mlig455_010809 {REF} {Length: 4442} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.1]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.4]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=740, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=744, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=740, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=694, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1017, Expect=0.0]} {RNA1509_34138} {RNA1310_12839, RNA1509_34138} {RNA1509_34138, RNA815_17637} |
36. | MligTC455_19225 | 26 | 0.54 | Mlig455_018507 | Neo: - Age: - |
SCNN1B | 0.977 | - | 0.977 | - | - | - | - | Mlig455_018507 {REF} {Length: 2590} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=142.8]} {Human: ENSG00000168447, SCNN1B, sodium channel epithelial 1 beta subunit, [Score=59.3, Expect=1e-08]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=60.8, Expect=1e-09]} {Smed: dd_Smed_v6_17245_0_1, dd_Smed_v6_17245_0_1, [Score=49.3, Expect=5e-06]} {RNA1509_52685} {RNA1310_32081} {RNA815_49764} |
37. | MligTC455_21684 | 5 | 0.11 | Mlig455_014284, Mlig455_014320, Mlig455_014336 | Neo: - Age: logFC(26M/2M)=-0.541 |
HECA | 0.977 | - | 0.977 | - | - | - | - | Mlig455_014284 {REF} {Length: 1986} {Pfam: Headcase protein [PF16002.7, score=201.7]; Headcase protein family homologue [PF15353.8, score=31.7]} {Human: ENSG00000112406, HECA, hdc homolog, cell cycle regulator, [RH, Score=145, Expect=8e-38]} {Mouse: ENSMUSG00000039879, Heca, hdc homolog, cell cycle regulator, [RH, Score=142, Expect=4e-37]} {Dmel: FBgn0010113, hdc, Histidine decarboxylase, [RH, Score=151, Expect=2e-39]} {Celegans: WBGene00010614, cri-1, Conserved Regulator of Innate immunity, [Score=98.2, Expect=1e-22]} {Smed: dd_Smed_v6_6218_0_1, dd_Smed_v6_6218_0_1, [RH, Score=167, Expect=4e-46]} {RNA1509_12340} {RNA1310_16685} {RNA815_9766} Mlig455_014320 {REF} {Length: 2086} {Pfam: Headcase protein [PF16002.7, score=201.7]; Headcase protein family homologue [PF15353.8, score=31.7]} {Human: ENSG00000112406, HECA, hdc homolog, cell cycle regulator, [RH, Score=145, Expect=8e-38]} {Mouse: ENSMUSG00000039879, Heca, hdc homolog, cell cycle regulator, [RH, Score=142, Expect=4e-37]} {Dmel: FBgn0010113, hdc, Histidine decarboxylase, [RH, Score=151, Expect=2e-39]} {Celegans: WBGene00010614, cri-1, Conserved Regulator of Innate immunity, [Score=98.2, Expect=1e-22]} {Smed: dd_Smed_v6_6218_0_1, dd_Smed_v6_6218_0_1, [RH, Score=167, Expect=4e-46]} {RNA1509_12340} {RNA1310_16685, RNA1509_12340} {RNA1509_12340, RNA815_9766} Mlig455_014336 {REF} {Length: 2009} {Pfam: Headcase protein [PF16002.7, score=201.7]; Headcase protein family homologue [PF15353.8, score=31.7]} {Human: ENSG00000112406, HECA, hdc homolog, cell cycle regulator, [RH, Score=145, Expect=7e-38]} {Mouse: ENSMUSG00000039879, Heca, hdc homolog, cell cycle regulator, [RH, Score=142, Expect=4e-37]} {Dmel: FBgn0010113, hdc, Histidine decarboxylase, [RH, Score=151, Expect=2e-39]} {Celegans: WBGene00010614, cri-1, Conserved Regulator of Innate immunity, [Score=98.2, Expect=1e-22]} {Smed: dd_Smed_v6_6218_0_1, dd_Smed_v6_6218_0_1, [RH, Score=166, Expect=6e-46]} {RNA1509_12340} {RNA1310_16685} {RNA815_9766} |
38. | MligTC455_23833 | 17 | 0.36 | Mlig455_016419 | Neo: - Age: - |
MYT1 | 0.977 | - | 0.977 | - | - | - | - | Mlig455_016419 {REF} {Length: 2682} {Pfam: Zinc finger, C2HC type [PF01530.20, score=79.8]} {Human: ENSG00000196132, MYT1, myelin transcription factor 1, [RH, Score=131, Expect=5e-32]; ENSG00000276876, MYT1, myelin transcription factor 1, [RH, Score=131, Expect=5e-32]; ENSG00000275018, AL121581.1, novel transcript, [RH, Score=130, Expect=1e-31]; ENSG00000147488, ST18, ST18, C2H2C-type zinc finger, [RH, Score=125, Expect=3e-30]} {Mouse: ENSMUSG00000010505, Myt1, myelin transcription factor 1, [RH, Score=132, Expect=6e-33]; ENSMUSG00000061911, Myt1l, myelin transcription factor 1-like, [RH, Score=129, Expect=1e-31]; ENSMUSG00000033740, St18, suppression of tumorigenicity 18, [RH, Score=126, Expect=2e-30]} {Dmel: FBgn0263772, CG43689, [RH, Score=99.0, Expect=1e-21]} {Celegans: WBGene00009939, ztf-11, Zinc finger putative Transcription Factor family, [RH, Score=121, Expect=1e-29]} {Smed: dd_Smed_v6_80183_0_2, dd_Smed_v6_80183_0_2, [Score=127, Expect=4e-34]} {RNA1310_143021} |
39. | MligTC455_26801 | 7 | 0.14 | Mlig455_024981 | Neo: - Age: - |
0.977 | - | 0.977 | - | - | - | - | Mlig455_024981 {REF} {Length: 847} {RNA1310_42506} {RNA815_41145} | |
40. | MligTC455_33853 | 7 | 0.14 | Mlig455_029940 | Neo: - Age: - |
MGAT1 | 0.977 | - | 0.977 | - | - | - | - | Mlig455_029940 {REF} {Length: 2088} {Pfam: GNT-I family [PF03071.17, score=204.9]} {Human: ENSG00000131446, MGAT1, mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase, [Score=153, Expect=4e-41]} {Mouse: ENSMUSG00000020346, Mgat1, mannoside acetylglucosaminyltransferase 1, [Score=166, Expect=4e-46]} {Dmel: FBgn0034521, Mgat1, Mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase 1, [Score=172, Expect=3e-48]} {Celegans: WBGene00001639, gly-14, GLYcosylation related; UDP-N-acetylglucosamine:a-3-D-mannoside b-1,2-N-acetylglucosaminyltransferase I, [Score=144, Expect=2e-38]} {Smed: dd_Smed_v6_13024_0_1, dd_Smed_v6_13024_0_1, [Score=158, Expect=1e-43]} {RNA1310_114996} |
41. | MligTC455_37412 | 95 | 1.98 | Mlig455_036605, Mlig455_036645 | Neo: - Age: - |
ADRA2A | 0.977 | - | 0.977 | - | - | - | - | Mlig455_036605 {REF} {Length: 3015} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=97.8]} {Human: ENSG00000150594, ADRA2A, adrenoceptor alpha 2A, [Score=55.5, Expect=2e-07]; ENSG00000082556, OPRK1, opioid receptor kappa 1, [Score=55.1, Expect=2e-07]} {Mouse: ENSMUSG00000033717, Adra2a, adrenergic receptor, alpha 2a, [Score=56.6, Expect=5e-08]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [Score=64.7, Expect=1e-10]} {Celegans: WBGene00016037, dop-6, DOPamine receptor, [Score=52.4, Expect=7e-07]} {Smed: dd_Smed_v6_23525_0_1, dd_Smed_v6_23525_0_1, [RH, Score=136, Expect=5e-35]} {RNA1310_57451} {RNA815_47300} Mlig455_036645 {REF} {Length: 3203} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=97.0]} {Human: ENSG00000150594, ADRA2A, adrenoceptor alpha 2A, [Score=55.5, Expect=2e-07]; ENSG00000082556, OPRK1, opioid receptor kappa 1, [Score=55.1, Expect=1e-07]} {Mouse: ENSMUSG00000033717, Adra2a, adrenergic receptor, alpha 2a, [Score=56.6, Expect=4e-08]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [Score=63.2, Expect=4e-10]} {Celegans: WBGene00016037, dop-6, DOPamine receptor, [Score=52.4, Expect=6e-07]} {Smed: dd_Smed_v6_23525_0_1, dd_Smed_v6_23525_0_1, [RH, Score=136, Expect=6e-35]} {RNA1310_57451} {RNA815_47300} |
42. | MligTC455_43137 | 118 | 2.46 | Mlig455_043159 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.878 Region-enriched R2: 5.988/0.00166 |
0.977 | - | 0.977 | - | - | - | - | Mlig455_043159 {REF} {Length: 1651} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=25.7]} {RNA1509_48871} {RNA1310_23692, RNA1509_48871} {RNA1509_48871, RNA815_11317} | |
43. | MligTC455_47997 | 36 | 0.75 | Mlig455_053262, Mlig455_065031 | Neo: - Age: - |
0.977 | - | 0.977 | - | - | - | - | Mlig455_053262 {REF} {Length: 927} {RNA1310_55950} {RNA815_42062.2} Mlig455_065031 {REF} {Length: 926} {RNA1310_55950} {RNA815_42062.2} |
|
44. | MligTC455_51603 | 39 | 0.81 | Mlig455_016769 | Neo: - Age: - |
0.977 | - | - | - | - | 0.977 | - | Mlig455_016769 {REF} {Length: 1577} {RNA1509_44500} {RNA1310_22352} {RNA815_21481} | |
45. | MligTC455_09802 | 39 | 0.81 | Mlig455_045247 | Neo: - Age: - |
0.976 | - | - | - | - | 0.976 | - | Mlig455_045247 {REF} {Length: 309} {NoTransDecoderORF} {tRNA: Val(CAC),pseudo, score=25.4} {RNA1509_45595} {RNA1310_67684} {RNA815_31014} | |
46. | MligTC455_10227 | 76 | 1.59 | Mlig455_023507, Mlig455_023516, Mlig455_023551 | Neo: - Age: - |
0.976 | - | 0.976 | - | - | - | - | Mlig455_023507 {REF} {Length: 1545} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=21.8]} {RNA1310_22533.3} {RNA815_23050} Mlig455_023516 {REF} {Length: 1641} {RNA1310_22533.3} {RNA815_23050} Mlig455_023551 {REF} {Length: 1638} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=22.2]} {RNA1310_22533.3} {RNA815_26724.1} |
|
47. | MligTC455_36096 | 3 | 0.06 | Mlig455_040358 | Neo: - Age: - |
0.976 | - | - | - | - | 0.976 | - | Mlig455_040358 {REF} {Length: 313} {RNA1509_10231} {RNA1310_38128} {RNA815_298.1} | |
48. | MligTC455_53349 | 48 | 1 | Mlig455_034044, Mlig455_060425 | Neo: - Age: - Region-enriched R8: 4.743/0.03399 |
0.975 | - | - | - | - | 0.975 | - | Mlig455_034044 {REF} {Length: 117} {NoTransDecoderORF} {RNA1310_129264} Mlig455_060425 {REF} {Length: 180} {NoTransDecoderORF} {RNA1310_129264} |
|
49. | MligTC455_10226 | 119 | 2.48 | Mlig455_023508, Mlig455_023518, Mlig455_023617 | Neo: - Age: - |
0.974 | - | 0.974 | - | - | - | - | Mlig455_023508 {REF} {Length: 1311} {RNA1310_22533.2} {RNA815_23050} Mlig455_023518 {REF} {Length: 1413} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=21.5]} {RNA1310_22533.2} {RNA815_23050} Mlig455_023617 {REF} {Length: 1414} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=19.6]} {RNA1310_22533.2} {RNA815_23050} |
|
50. | MligTC455_10228 | 50 | 1.05 | Mlig455_023553 | Neo: - Age: - |
0.974 | - | 0.974 | - | - | - | - | Mlig455_023553 {REF} {Length: 1195} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=20.0]} {RNA1310_22533.1} {RNA815_23050} | |
51. | MligTC455_09416 | 15 | 0.32 | Mlig455_025505, Mlig455_025526 | Neo: - Age: - |
HRH1 | 0.973 | - | 0.973 | - | - | - | - | Mlig455_025505 {REF} {Length: 1843} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=122.8]} {Human: ENSG00000196639, HRH1, histamine receptor H1, [Score=131, Expect=4e-34]} {Mouse: ENSMUSG00000053004, Hrh1, histamine receptor H1, [Score=127, Expect=9e-33]} {Dmel: FBgn0000037, mAChR-A, muscarinic Acetylcholine Receptor, A-type, [Score=113, Expect=2e-27]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=102, Expect=4e-24]} {Smed: dd_Smed_v6_15040_0_1, dd_Smed_v6_15040_0_1, [Score=99.4, Expect=4e-23]} {RNA1509_53354} {RNA1310_79526} {RNA815_31150} Mlig455_025526 {REF} {Length: 2045} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=247.0]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=30.1]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=25.8]; Olfactory receptor [PF13853.8, score=23.3]} {Human: ENSG00000196639, HRH1, histamine receptor H1, [RH, Score=264, Expect=2e-82]} {Mouse: ENSMUSG00000053004, Hrh1, histamine receptor H1, [RH, Score=264, Expect=2e-82]} {Dmel: FBgn0004514, Oct-TyrR, Octopamine-Tyramine receptor, [Score=192, Expect=2e-54]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=187, Expect=4e-53]} {Smed: dd_Smed_v6_48706_0_1, dd_Smed_v6_48706_0_1, [Score=189, Expect=2e-55]} {RNA1509_53354} {RNA1310_79526} {RNA815_31150} |
52. | MligTC455_17266 | 62 | 1.3 | Mlig455_043650 | Neo: - Age: - |
0.973 | - | 0.973 | - | - | - | - | Mlig455_043650 {REF} {Length: 2826} {RNA1310_48878} {RNA815_25527} | |
53. | MligTC455_17394 | 41 | 0.85 | Mlig455_013077 | Neo: - Age: - |
0.973 | - | 0.973 | - | - | - | - | Mlig455_013077 {REF} {Length: 1066} {RNA1310_66954} {RNA815_27868} | |
54. | MligTC455_41443 | 382 | 7.96 | Mlig455_034791, Mlig455_034803 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-1.360 Region-enriched R2: 5.869/0.00205 |
0.972 | - | 0.972 | - | - | - | - | Mlig455_034791 {REF} {Length: 996} {RNA1310_39610.1} {RNA815_26421} Mlig455_034803 {REF} {Length: 1084} {RNA1310_39610.1} {RNA815_26421} |
|
55. | MligTC455_49922 | 36 | 0.76 | Mlig455_049338 | Neo: - Age: Down-Down-Up Region-enriched R2: 7.622/0.00496 |
0.972 | - | 0.972 | - | - | - | - | Mlig455_049338 {REF} {Length: 971} {RNA1310_37449} {RNA815_3585} | |
56. | MligTC455_53658 | 41 | 0.86 | Mlig455_070698 | Neo: - Age: Up-Down-Down Region-enriched R2: 9.084/0.01491 |
0.972 | - | 0.972 | - | - | - | - | Mlig455_070698 {REF} {Length: 1026} {RNA1509_40972} {RNA1310_35649.1} {RNA815_17004} | |
57. | MligTC455_52527 | 28 | 0.58 | Mlig455_025836 | Neo: - Age: - |
FLVCR2 | 0.971 | - | 0.971 | - | - | - | - | Mlig455_025836 {REF} {Length: 2177} {TRANSSPLICED} {Pfam: Major Facilitator Superfamily [PF07690.18, score=81.4]; Sugar (and other) transporter [PF00083.26, score=18.7]} {Human: ENSG00000119686, FLVCR2, feline leukemia virus subgroup C cellular receptor family member 2, [RH, Score=364, Expect=5e-119]} {Mouse: ENSMUSG00000034258, Flvcr2, feline leukemia virus subgroup C cellular receptor 2, [RH, Score=367, Expect=3e-120]} {Dmel: FBgn0033196, CG1358, [RH, Score=350, Expect=1e-114]} {Celegans: WBGene00015632, C09D4.1, Uncharacterized MFS-type transporter C09D4.1, [RH, Score=358, Expect=1e-116]} {Smed: dd_Smed_v6_7578_0_1, dd_Smed_v6_7578_0_1, [Score=335, Expect=3e-109]} {RNA1509_31725} {RNA1310_8852.1} {RNA815_14234} |
58. | MligTC455_46281 | 22 | 0.45 | Mlig455_016138 | Neo: Irradiation Age: - |
KDELR2 | 0.97 | - | 0.970 | - | - | - | - | Mlig455_016138 {REF} {Length: 2664} {TRANSSPLICED} {Pfam: ER lumen protein retaining receptor [PF00810.20, score=173.9]; Intermediate filament protein [PF00038.23, score=132.5]; Lamin Tail Domain [PF00932.21, score=37.2]} {Human: ENSG00000136240, KDELR2, KDEL endoplasmic reticulum protein retention receptor 2, [Score=293, Expect=2e-93]} {Mouse: ENSMUSG00000079111, Kdelr2, KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2, [Score=296, Expect=1e-94]} {Dmel: FBgn0267330, KdelR, KDEL receptor, [Score=291, Expect=4e-93]} {Celegans: WBGene00001331, erd-2, ER lumen protein-retaining receptor, [Score=266, Expect=2e-83]} {Smed: dd_Smed_v6_1592_0_1, dd_Smed_v6_1592_0_1, [Score=283, Expect=8e-90]} {RNA1509_3479} {RNA1310_8292} {RNA815_3092.1} |
59. | MligTC455_08407 | 22 | 0.46 | Mlig455_043162 | Neo: - Age: - |
0.969 | - | 0.969 | - | - | - | - | Mlig455_043162 {REF} {Length: 1257} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=20.7]} {RNA1310_58288} {RNA815_55196} | |
60. | MligTC455_16123 | 16 | 0.34 | Mlig455_017712, Mlig455_017765 | Neo: - Age: - |
GABRA3, GABRA4 | 0.969 | - | - | - | - | 0.969 | - | Mlig455_017712 {REF} {Length: 1526} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=157.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=96.6]} {Human: ENSG00000109158, GABRA4, gamma-aminobutyric acid type A receptor alpha4 subunit, [RH, Score=284, Expect=3e-89]; ENSG00000113327, GABRG2, gamma-aminobutyric acid type A receptor gamma2 subunit, [RH, Score=280, Expect=2e-88]} {Mouse: ENSMUSG00000020428, Gabra6, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 6, [RH, Score=294, Expect=2e-94]; ENSMUSG00000029211, Gabra4, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 4, [RH, Score=283, Expect=3e-89]} {Dmel: FBgn0030707, CG8916, [Score=346, Expect=4e-114]} {Celegans: WBGene00008551, lgc-36, Ligand-Gated ion Channel, [RH, Score=278, Expect=1e-87]} {Smed: dd_Smed_v6_24908_0_1, dd_Smed_v6_24908_0_1, [Score=404, Expect=2e-138]} {RNA1310_12235.2} {RNA815_15667.1} Mlig455_017765 {REF} {Length: 1428} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=65.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=51.8]} {Human: ENSG00000011677, GABRA3, gamma-aminobutyric acid type A receptor alpha3 subunit, [Score=151, Expect=1e-40]; ENSG00000186297, GABRA5, gamma-aminobutyric acid type A receptor alpha5 subunit, [Score=147, Expect=2e-39]; ENSG00000109158, GABRA4, gamma-aminobutyric acid type A receptor alpha4 subunit, [Score=147, Expect=1e-38]; ENSG00000145863, GABRA6, gamma-aminobutyric acid type A receptor alpha6 subunit, [Score=145, Expect=1e-38]; ENSG00000113327, GABRG2, gamma-aminobutyric acid type A receptor gamma2 subunit, [Score=144, Expect=9e-38]} {Mouse: ENSMUSG00000020428, Gabra6, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 6, [Score=155, Expect=1e-42]} {Dmel: FBgn0030707, CG8916, [Score=199, Expect=1e-58]} {Celegans: WBGene00013914, lgc-37, Ligand-Gated ion Channel, [Score=163, Expect=2e-45]} {Smed: dd_Smed_v6_24908_0_1, dd_Smed_v6_24908_0_1, [Score=209, Expect=2e-63]} {RNA1310_65637} {RNA815_15667.1} |
61. | MligTC455_11430 | 15 | 0.31 | Mlig455_030266 | Neo: - Age: - |
KIAA1614 | 0.968 | - | - | - | - | 0.968 | - | Mlig455_030266 {REF} {Length: 2564} {Human: ENSG00000135835, KIAA1614, KIAA1614, [Score=61.2, Expect=2e-10]} {Mouse: ENSMUSG00000033722, BC034090, cDNA sequence BC034090, [Score=61.2, Expect=9e-10]} {Celegans: WBGene00006363, syd-1, Rho GTPase-activating protein syd-1, [Score=50.4, Expect=1e-06]} {RNA1310_86711} {RNA815_36990} |
62. | MligTC455_13395 | 18 | 0.38 | Mlig455_061750 | Neo: - Age: - |
QRFPR | 0.968 | - | 0.968 | - | - | - | - | Mlig455_061750 {REF} {Length: 1579} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=107.1]} {Human: ENSG00000186867, QRFPR, pyroglutamylated RFamide peptide receptor, [Score=99.8, Expect=2e-22]} {Mouse: ENSMUSG00000035528, Npffr2, neuropeptide FF receptor 2, [Score=92.8, Expect=2e-20]} {Dmel: FBgn0050106, CCHa1-R, CCHamide-1 receptor, [Score=78.6, Expect=1e-15]} {Celegans: WBGene00021983, npr-5, NeuroPeptide Receptor family, [Score=77.4, Expect=2e-15]} {Smed: dd_Smed_v6_14520_0_1, dd_Smed_v6_14520_0_1, [Score=73.9, Expect=2e-14]} {RNA1310_103173} {RNA815_39338} |
63. | MligTC455_18140 | 171 | 3.56 | Mlig455_033232 | Neo: - Age: Up-Down-Down Region-specific R2: 6.925 Region-enriched R2: 6.274/0.02921 |
TRPC5 | 0.968 | - | 0.968 | - | - | - | - | Mlig455_033232 {REF} {Length: 4524} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.2]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.5]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=742, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=745, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=742, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=696, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1016, Expect=0.0]} {RNA1509_34138} {RNA1310_12839} {RNA815_17637} |
64. | MligTC455_17479 | 32 | 0.66 | Mlig455_032081, Mlig455_070278 | Neo: - Age: logFC(26M/2M)=-0.516 |
CHRNA3 | 0.967 | - | 0.967 | - | - | - | - | Mlig455_032081 {REF} {Length: 2787} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=230.7]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=221.4]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=368, Expect=1e-121]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=366, Expect=5e-121]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=378, Expect=6e-126]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=361, Expect=3e-119]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=461, Expect=3e-158]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=381, Expect=3e-127]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=614, Expect=0.0]} {RNA1509_28642} {RNA1310_34709} {RNA815_44960} Mlig455_070278 {REF} {Length: 2270} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=232.1]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=221.2]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=369, Expect=7e-122]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=366, Expect=4e-121]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=378, Expect=9e-126]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=362, Expect=1e-119]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=461, Expect=3e-158]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=382, Expect=2e-127]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=616, Expect=0.0]} {RNA1509_16247} {RNA1310_34709} {RNA815_44960} |
65. | MligTC455_23220 | 56 | 1.18 | Mlig455_060190 | Neo: - Age: - |
ACKR3 | 0.966 | - | 0.966 | - | - | - | - | Mlig455_060190 {REF} {Length: 2108} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=106.0]} {Human: ENSG00000144476, ACKR3, atypical chemokine receptor 3, [RH, Score=99.0, Expect=1e-22]} {Mouse: ENSMUSG00000026180, Cxcr2, chemokine (C-X-C motif) receptor 2, [Score=112, Expect=1e-27]} {Dmel: FBgn0266429, AstA-R1, Allatostatin A receptor 1, [Score=102, Expect=4e-24]} {Celegans: WBGene00021439, ckr-2, CholecystoKinin Receptor homolog; Cholecystokinin receptor 2 splice isoform b, [Score=68.2, Expect=2e-12]} {Smed: dd_Smed_v6_10325_0_1, dd_Smed_v6_10325_0_1, [Score=81.6, Expect=5e-17]} {RNA1310_66504} {RNA815_39432} |
66. | MligTC455_23239 | 32 | 0.67 | Mlig455_030867 | Neo: - Age: - |
PRKCB | 0.966 | - | 0.966 | - | - | - | - | Mlig455_030867 {REF} {Length: 3999} {Pfam: Protein kinase domain [PF00069.27, score=228.1]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=131.0]; Phorbol esters/diacylglycerol binding domain (C1 domain) [PF00130.24, score=118.5]; C2 domain [PF00168.32, score=93.9]; Protein kinase C terminal domain [PF00433.26, score=35.3]; C1 domain [PF03107.18, score=22.2]; Kinase-like [PF14531.8, score=19.0]} {Human: ENSG00000166501, PRKCB, protein kinase C beta, [RH, Score=962, Expect=0.0]; ENSG00000154229, PRKCA, protein kinase C alpha, [RH, Score=952, Expect=0.0]} {Mouse: ENSMUSG00000052889, Prkcb, protein kinase C, beta, [RH, Score=963, Expect=0.0]; ENSMUSG00000050965, Prkca, protein kinase C, alpha, [RH, Score=952, Expect=0.0]} {Dmel: FBgn0003091, Pkc53E, Protein C kinase 53E, [RH, Score=941, Expect=0.0]} {Celegans: WBGene00004033, pkc-2, Protein kinase C-like 2, [RH, Score=940, Expect=0.0]} {Smed: dd_Smed_v6_4244_0_2, dd_Smed_v6_4244_0_2, [RH, Score=1049, Expect=0.0]} {RNA1509_51260} {RNA1310_9698, RNA1509_51260} {RNA1509_51260, RNA815_24870} |
67. | MligTC455_35000 | 20 | 0.42 | Mlig455_050562 | Neo: - Age: - |
KCNC1 | 0.966 | - | 0.966 | - | - | - | - | Mlig455_050562 {REF} {Length: 3042} {Pfam: Ion transport protein [PF00520.33, score=116.8]; BTB/POZ domain [PF02214.24, score=75.0]; Ion channel [PF07885.18, score=42.0]} {Human: ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=211, Expect=2e-60]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=209, Expect=1e-58]; ENSG00000182674, KCNB2, potassium voltage-gated channel subfamily B member 2, [Score=206, Expect=3e-56]; ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=204, Expect=3e-57]; ENSG00000158445, KCNB1, potassium voltage-gated channel subfamily B member 1, [Score=204, Expect=1e-55]; ENSG00000131398, KCNC3, potassium voltage-gated channel subfamily C member 3, [Score=203, Expect=7e-56]} {Mouse: ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=212, Expect=3e-60]; ENSMUSG00000050556, Kcnb1, potassium voltage gated channel, Shab-related subfamily, member 1, [Score=209, Expect=2e-57]; ENSMUSG00000092083, Kcnb2, potassium voltage gated channel, Shab-related subfamily, member 2, [Score=206, Expect=2e-56]; ENSMUSG00000027895, Kcnc4, potassium voltage gated channel, Shaw-related subfamily, member 4, [Score=204, Expect=4e-57]; ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=203, Expect=1e-56]; ENSMUSG00000062785, Kcnc3, potassium voltage gated channel, Shaw-related subfamily, member 3, [Score=203, Expect=4e-56]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=223, Expect=2e-65]} {Celegans: WBGene00008819, shw-1, SHaW family of potassium channels, [Score=224, Expect=8e-65]} {Smed: dd_Smed_v6_20858_0_1, dd_Smed_v6_20858_0_1, [RH, Score=567, Expect=0.0]} {RNA1509_22940} {RNA1310_28483} {RNA815_31040} |
68. | MligTC455_41436 | 50 | 1.04 | Mlig455_038820, Mlig455_038831, Mlig455_038905 | Neo: - Age: Up-Down-Down |
PCDHA1 | 0.966 | - | - | - | - | 0.966 | - | Mlig455_038820 {REF} {Length: 5696} {Pfam: Cadherin domain [PF00028.19, score=219.7]; Cadherin-like [PF16184.7, score=28.8]; Cadherin-like [PF08266.14, score=20.3]} {Human: ENSG00000204970, PCDHA1, protocadherin alpha 1, [Score=229, Expect=3e-61]; ENSG00000156453, PCDH1, protocadherin 1, [Score=223, Expect=6e-59]; ENSG00000253953, PCDHGB4, protocadherin gamma subfamily B, 4, [Score=218, Expect=9e-58]} {Mouse: ENSMUSG00000103585, Pcdhgb4, protocadherin gamma subfamily B, 4, [Score=227, Expect=5e-61]; ENSMUSG00000051375, Pcdh1, protocadherin 1, [Score=225, Expect=5e-60]; ENSMUSG00000103749, Pcdhgb5, protocadherin gamma subfamily B, 5, [Score=225, Expect=2e-60]; ENSMUSG00000104063, Pcdhgb7, protocadherin gamma subfamily B, 7, [Score=217, Expect=1e-57]; ENSMUSG00000103442, Pcdha1, protocadherin alpha 1, [Score=216, Expect=2e-57]} {Dmel: FBgn0284247, ds, dachsous, [Score=180, Expect=2e-45]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=133, Expect=5e-31]} {Smed: dd_Smed_v6_13040_0_1, dd_Smed_v6_13040_0_1, [RH, Score=379, Expect=7e-114]} {RNA1509_45283} {RNA1310_7504, RNA1509_45283} {RNA1509_45283, RNA815_15214} Mlig455_038831 {REF} {Length: 3827} {Pfam: Cadherin domain [PF00028.19, score=208.3]; Cadherin-like [PF16184.7, score=26.1]; Cadherin-like [PF08266.14, score=18.5]} {Human: ENSG00000204970, PCDHA1, protocadherin alpha 1, [Score=209, Expect=8e-55]; ENSG00000156453, PCDH1, protocadherin 1, [Score=205, Expect=3e-53]; ENSG00000253953, PCDHGB4, protocadherin gamma subfamily B, 4, [Score=199, Expect=9e-52]; ENSG00000253910, PCDHGB2, protocadherin gamma subfamily B, 2, [Score=199, Expect=6e-52]} {Mouse: ENSMUSG00000051375, Pcdh1, protocadherin 1, [Score=208, Expect=1e-54]; ENSMUSG00000103749, Pcdhgb5, protocadherin gamma subfamily B, 5, [Score=202, Expect=4e-53]; ENSMUSG00000103585, Pcdhgb4, protocadherin gamma subfamily B, 4, [Score=201, Expect=2e-52]} {Dmel: FBgn0024836, stan, starry night, [Score=161, Expect=1e-39]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=130, Expect=3e-30]} {Smed: dd_Smed_v6_13040_0_1, dd_Smed_v6_13040_0_1, [Score=352, Expect=5e-104]} {RNA1509_45283} {RNA1310_7504} {RNA815_15214} Mlig455_038905 {REF} {Length: 4854} {Pfam: Cadherin domain [PF00028.19, score=220.4]; Cadherin-like [PF16184.7, score=28.3]} {Human: ENSG00000204970, PCDHA1, protocadherin alpha 1, [Score=230, Expect=2e-62]; ENSG00000156453, PCDH1, protocadherin 1, [Score=225, Expect=2e-59]} {Mouse: ENSMUSG00000051375, Pcdh1, protocadherin 1, [Score=227, Expect=2e-60]; ENSMUSG00000103749, Pcdhgb5, protocadherin gamma subfamily B, 5, [Score=224, Expect=3e-60]; ENSMUSG00000103585, Pcdhgb4, protocadherin gamma subfamily B, 4, [Score=223, Expect=6e-60]} {Dmel: FBgn0284247, ds, dachsous, [Score=182, Expect=7e-46]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=151, Expect=1e-36]} {Smed: dd_Smed_v6_13040_0_1, dd_Smed_v6_13040_0_1, [RH, Score=377, Expect=5e-113]} {RNA1509_45283} {RNA1310_7504} {RNA815_15214} |
69. | MligTC455_08724 | 7 | 0.14 | Mlig455_008878 | Neo: - Age: - |
TENT5D | 0.965 | - | 0.965 | - | - | - | - | Mlig455_008878 {REF} {Length: 2482} {Pfam: Nucleotidyltransferase [PF07984.14, score=304.0]} {Human: ENSG00000174016, TENT5D, terminal nucleotidyltransferase 5D, [Score=248, Expect=8e-77]; ENSG00000183508, TENT5C, terminal nucleotidyltransferase 5C, [Score=246, Expect=4e-76]; ENSG00000112773, TENT5A, terminal nucleotidyltransferase 5A, [Score=239, Expect=1e-72]} {Mouse: ENSMUSG00000073007, Tent5d, terminal nucleotidyltransferase 5D, [Score=244, Expect=8e-76]; ENSMUSG00000044468, Tent5c, terminal nucleotidyltransferase 5C, [Score=243, Expect=3e-75]; ENSMUSG00000032265, Tent5a, terminal nucleotidyltransferase 5A, [Score=242, Expect=2e-74]} {Dmel: FBgn0050497, CG30497, [Score=244, Expect=2e-74]} {Celegans: WBGene00004131, pqn-44, Prion-like-(Q/N-rich)-domain-bearing protein, [RH, Score=209, Expect=2e-61]} {Smed: dd_Smed_v6_11571_0_1, dd_Smed_v6_11571_0_1, [Score=254, Expect=8e-80]} {RNA1310_116080} |
70. | MligTC455_33850 | 80 | 1.67 | Mlig455_015720 | Neo: - Age: - Region-enriched R2: 4.134/0.00338 |
0.963 | - | 0.963 | - | - | - | - | Mlig455_015720 {REF} {Length: 829} {RNA1509_37932} {RNA1310_98453} | |
71. | MligTC455_39985 | 28 | 0.58 | Mlig455_022339, Mlig455_022351 | Neo: - Age: - |
0.963 | - | - | - | - | 0.963 | - | Mlig455_022339 {REF} {Length: 783} {RNA1509_47318} {RNA1310_125793} {RNA815_2914.1} Mlig455_022351 {REF} {Length: 1105} {Pfam: WSC domain [PF01822.21, score=64.2]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=64.7, Expect=8e-12]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=51.6, Expect=2e-07]} {RNA1310_59980.1} {RNA815_55549} |
|
72. | MligTC455_24740 | 54 | 1.13 | Mlig455_036332, Mlig455_036355 | Neo: - Age: - |
0.962 | - | - | - | - | 0.962 | - | Mlig455_036332 {REF} {Length: 268} {NoTransDecoderORF} Mlig455_036355 {REF} {Length: 3796} {RNA1310_76210} |
|
73. | MligTC455_12377 | 14 | 0.29 | Mlig455_022784 | Neo: - Age: - |
0.961 | - | 0.961 | - | - | - | - | Mlig455_022784 {REF} {Length: 1064} {RNA1310_136157} | |
74. | MligTC455_13903 | 648 | 13.5 | Mlig455_013116 | Neo: - Age: logFC(26M/2M)=-1.026 Region-specific R2: 6.980 Region-enriched R2: 7.338/0.00000 |
0.961 | - | 0.961 | - | - | - | - | Mlig455_013116 {REF} {Length: 914} {RNA1509_28527} {RNA1310_38436.2, RNA1509_28527} {RNA1509_28527, RNA815_28856} | |
75. | MligTC455_15178 | 6 | 0.13 | Mlig455_027247 | Neo: - Age: - |
0.961 | - | - | - | - | 0.961 | - | Mlig455_027247 {REF} {Length: 923} {NoTransDecoderORF} {RNA1310_42563} | |
76. | MligTC455_38121 | 24 | 0.5 | Mlig455_043084 | Neo: - Age: - |
0.961 | - | - | - | - | 0.961 | - | Mlig455_043084 {REF} {Length: 3258} {NoTransDecoderORF} {RNA1509_41513} {RNA1310_17939.1, RNA1509_41513} {RNA1509_41513, RNA815_16258} | |
77. | MligTC455_54101 | 22 | 0.46 | Mlig455_027714, Mlig455_027916 | Neo: - Age: Down-Down-Up Region-enriched R2: 6.959/0.00611 |
0.961 | - | 0.961 | - | - | - | - | Mlig455_027714 {REF} {Length: 2191} {RNA1509_18336} {RNA1310_16542.1} {RNA815_13433} Mlig455_027916 {REF} {Length: 2184} {RNA1509_18336} {RNA1310_16542.1} {RNA815_13433} |
|
78. | MligTC455_37444 | 4098 | 85.37 | Mlig455_005616, Mlig455_014433, Mlig455_057559, Mlig455_070182 | Neo: - Age: - Region-enriched R2: 1.909/0.00760 |
0.96 | - | 0.960 | - | - | - | - | Mlig455_005616 {REF} {Length: 641} {TRANSSPLICED} {RNA1509_33612} {RNA1310_64994.1} {RNA815_13049.1} Mlig455_014433 {REF} {Length: 626} {TRANSSPLICED} {RNA1509_33612} {RNA1310_64994.1} {RNA815_13049.1} Mlig455_057559 {REF} {Length: 1151} {RNA1310_107958} Mlig455_070182 {REF} {Length: 638} {TRANSSPLICED} {RNA1509_33612} {RNA1310_64994.1, RNA1509_33612} {RNA1509_33612, RNA815_13049.1} |
|
79. | MligTC455_17363 | 62 | 1.28 | Mlig455_003936 | Neo: - Age: - |
0.959 | - | 0.959 | - | - | - | - | Mlig455_003936 {REF} {Length: 1252} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=45.9]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=26.4]} {RNA1310_47889} {RNA815_24646} | |
80. | MligTC455_20428 | 37 | 0.78 | Mlig455_050428 | Neo: - Age: Up-Down-Down Region-enriched R2: 7.829/0.00010 |
LRRN3 | 0.959 | - | 0.959 | - | - | - | - | Mlig455_050428 {REF} {Length: 10329} {Pfam: Leucine rich repeat [PF13855.8, score=96.2]; Leucine Rich repeats (2 copies) [PF12799.9, score=63.4]; Immunoglobulin domain [PF13927.8, score=44.7]; Immunoglobulin I-set domain [PF07679.18, score=41.3]; Immunoglobulin domain [PF00047.27, score=31.4]; Leucine-rich repeat [PF14580.8, score=24.8]; Immunoglobulin V-set domain [PF07686.19, score=23.1]; Immunoglobulin domain [PF13895.8, score=22.9]; Leucine Rich Repeat [PF00560.35, score=20.8]} {Human: ENSG00000173114, LRRN3, leucine rich repeat neuronal 3, [RH, Score=114, Expect=2e-25]; ENSG00000174482, LINGO2, leucine rich repeat and Ig domain containing 2, [RH, Score=112, Expect=3e-25]; ENSG00000175928, LRRN1, leucine rich repeat neuronal 1, [RH, Score=111, Expect=2e-24]} {Mouse: ENSMUSG00000036295, Lrrn3, leucine rich repeat protein 3, neuronal, [RH, Score=113, Expect=2e-25]; ENSMUSG00000045083, Lingo2, leucine rich repeat and Ig domain containing 2, [RH, Score=110, Expect=1e-24]; ENSMUSG00000034648, Lrrn1, leucine rich repeat protein 1, neuronal, [RH, Score=108, Expect=5e-24]} {Dmel: FBgn0032479, CG16974, [Score=89.0, Expect=1e-17]} {Celegans: WBGene00020649, sma-10, Leucine-rich repeats and immunoglobulin-like domains protein sma-10, [Score=73.6, Expect=4e-13]} {RNA1509_34876} {RNA1310_313, RNA1509_34876} {RNA1509_34876, RNA815_2616} |
81. | MligTC455_33778 | 301 | 6.27 | Mlig455_039535 | Neo: - Age: - |
0.959 | - | - | - | - | 0.959 | - | Mlig455_039535 {REF} {Length: 1526} {NoTransDecoderORF} {RNA1509_24833} {RNA1310_46713} {RNA815_28917} | |
82. | MligTC455_35103 | 102 | 2.12 | Mlig455_023928 | Neo: - Age: logFC(26M/2M)=-1.570 Region-enriched R2: 8.161/0.00000 |
OPN4 | 0.959 | - | 0.959 | - | - | - | - | Mlig455_023928 {REF} {Length: 2781} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=179.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=34.7]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=28.9]; Olfactory receptor [PF13853.8, score=24.6]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=19.1]} {Human: ENSG00000122375, OPN4, opsin 4, [RH, Score=218, Expect=2e-65]} {Mouse: ENSMUSG00000021799, Opn4, opsin 4 (melanopsin), [RH, Score=225, Expect=1e-68]} {Dmel: FBgn0014019, Rh5, Rhodopsin 5, [RH, Score=222, Expect=2e-68]} {Celegans: WBGene00009619, npr-6, NeuroPeptide Receptor family, [Score=91.3, Expect=4e-20]} {Smed: dd_Smed_v6_15036_0_1, dd_Smed_v6_15036_0_1, [RH, Score=520, Expect=0.0]} {RNA1509_41123} {RNA1310_10673, RNA1509_41123} {RNA1509_41123, RNA815_4962} |
83. | MligTC455_12894 | 84 | 1.75 | Mlig455_024418, Mlig455_024572 | Neo: - Age: - Region-enriched R2: 5.211/0.02671 |
SLC46A2 | 0.958 | - | 0.958 | - | - | - | - | Mlig455_024418 {REF} {Length: 2094} {Pfam: Major Facilitator Superfamily [PF07690.18, score=30.9]} {Human: ENSG00000119457, SLC46A2, solute carrier family 46 member 2, [Score=72.4, Expect=2e-13]} {Mouse: ENSMUSG00000020829, Slc46a1, solute carrier family 46, member 1, [Score=55.1, Expect=5e-08]} {Dmel: FBgn0030576, CG15890, [Score=68.9, Expect=1e-12]} {Celegans: WBGene00012811, Y43F8A.5, [Score=65.9, Expect=9e-12]} {Smed: dd_Smed_v6_10822_0_1, dd_Smed_v6_10822_0_1, [Score=187, Expect=2e-55]} {RNA1509_40290} {RNA1310_44254} {RNA815_43004} Mlig455_024572 {REF} {Length: 1344} {Pfam: Major Facilitator Superfamily [PF07690.18, score=30.9]} {Human: ENSG00000119457, SLC46A2, solute carrier family 46 member 2, [Score=72.4, Expect=2e-13]} {Mouse: ENSMUSG00000020829, Slc46a1, solute carrier family 46, member 1, [Score=55.1, Expect=5e-08]} {Dmel: FBgn0030576, CG15890, [Score=68.9, Expect=1e-12]} {Celegans: WBGene00012811, Y43F8A.5, [Score=65.9, Expect=9e-12]} {Smed: dd_Smed_v6_10822_0_1, dd_Smed_v6_10822_0_1, [Score=187, Expect=2e-55]} {RNA1509_40290} {RNA1310_71457} {RNA815_15082} |
84. | MligTC455_36566 | 40 | 0.83 | Mlig455_053263 | Neo: - Age: - Region-enriched R2: 4.823/0.01830 |
0.958 | - | 0.958 | - | - | - | - | Mlig455_053263 {REF} {Length: 1228} {TRANSSPLICED} {RNA1310_99871} | |
85. | MligTC455_49843 | 70 | 1.46 | Mlig455_058264, Mlig455_058281, Mlig455_070786 | Neo: - Age: - |
CHRNA3, CHRNA7 | 0.958 | - | 0.958 | - | - | - | - | Mlig455_058264 {REF} {Length: 2377} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=149.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=103.7]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=224, Expect=4e-66]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=216, Expect=2e-63]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=223, Expect=8e-66]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=220, Expect=8e-65]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=219, Expect=6e-65]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=213, Expect=4e-62]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=240, Expect=3e-72]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=229, Expect=7e-69]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=227, Expect=1e-67]} {RNA1310_31785} {RNA815_40862} Mlig455_058281 {REF} {Length: 2912} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=179.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=105.5]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=239, Expect=1e-71]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=239, Expect=1e-71]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=238, Expect=4e-71]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=236, Expect=1e-70]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=231, Expect=2e-69]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=229, Expect=4e-68]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=240, Expect=3e-72]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=232, Expect=3e-69]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=231, Expect=7e-69]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=228, Expect=3e-68]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=252, Expect=2e-76]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=250, Expect=1e-76]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=239, Expect=7e-72]} {RNA1310_31785} {RNA815_40862} Mlig455_070786 {REF} {Length: 1486} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=36.1]} {RNA1310_31785} {RNA815_43410} |
86. | MligTC455_53586 | 32 | 0.66 | Mlig455_061060 | Neo: - Age: - |
0.958 | - | 0.958 | - | - | - | - | Mlig455_061060 {REF} {Length: 1466} {RNA1310_93934} {RNA815_37442} | |
87. | MligTC455_53657 | 221 | 4.6 | Mlig455_039396 | Neo: - Age: - Region-enriched R2: 6.078/0.00340 |
0.958 | - | 0.958 | - | - | - | - | Mlig455_039396 {REF} {Length: 1026} {Pfam: emp24/gp25L/p24 family/GOLD [PF01105.26, score=21.0]} {RNA1509_40972} {RNA1310_35649.1, RNA1509_40972} {RNA1509_40972, RNA815_17004} | |
88. | MligTC455_54845 | 7 | 0.16 | Mlig455_011372 | Neo: - Age: - |
0.958 | - | - | - | - | 0.958 | - | Mlig455_011372 {REF} {Length: 312} {NoTransDecoderORF} | |
89. | MligTC455_51913 | 10 | 0.22 | Mlig455_027292 | Neo: - Age: - |
0.957 | - | - | - | - | 0.957 | - | Mlig455_027292 {REF} {Length: 623} {NoTransDecoderORF} {RNA1310_29520} | |
90. | MligTC455_12886 | 7 | 0.15 | Mlig455_062770 | Neo: - Age: - |
0.956 | - | 0.956 | - | - | - | - | Mlig455_062770 {REF} {Length: 486} {RNA1310_94667} | |
91. | MligTC455_21304 | 7 | 0.15 | Mlig455_061099 | Neo: - Age: - |
0.956 | - | - | - | - | 0.956 | - | Mlig455_061099 {REF} {Length: 1248} {RNA1310_36349} {RNA815_50494} | |
92. | MligTC455_30634 | 114 | 2.38 | Mlig455_025888 | Neo: - Age: Up-Down-Up Region-enriched R2: 6.750/0.00140 |
0.956 | - | 0.956 | - | - | - | - | Mlig455_025888 {REF} {Length: 5266} {Pfam: Integrase core domain [PF00665.28, score=50.8]; DDE superfamily endonuclease [PF13358.8, score=22.0]} {Smed: dd_Smed_v6_1574_6_72, dd_Smed_v6_1574_6_72, [Score=149, Expect=3e-41]} {RNA1509_47056} {RNA1310_5710.1} {RNA815_6291.1} | |
93. | MligTC455_30643 | 29 | 0.6 | Mlig455_011351 | Neo: - Age: Up-Down-Down |
SACS | 0.956 | - | - | - | - | 0.956 | - | Mlig455_011351 {REF} {Length: 19090} {Pfam: HEPN domain [PF05168.16, score=58.1]; Protein of unknown function (DUF3684) [PF12449.10, score=23.3]; Bacterial protein of unknown function (DUF896) [PF05979.14, score=18.6]} {Human: ENSG00000151835, SACS, sacsin molecular chaperone, [Score=617, Expect=2e-176]} {Mouse: ENSMUSG00000048279, Sacs, sacsin, [RH, Score=608, Expect=8e-174]} {RNA1509_56235} {RNA1310_2346.1} {RNA815_63.1} |
94. | MligTC455_01861 | 30 | 0.63 | Mlig455_046027 | Neo: - Age: - |
0.955 | - | 0.955 | - | - | - | - | Mlig455_046027 {REF} {Length: 736} {RNA1310_50531} {RNA815_29422} | |
95. | MligTC455_05659 | 9 | 0.19 | Mlig455_000779 | Neo: - Age: - |
0.954 | - | 0.954 | - | - | - | - | Mlig455_000779 {REF} {Length: 525} {RNA1509_14736} {RNA1310_6965} {RNA815_41421} | |
96. | MligTC455_11716 | 16 | 0.32 | Mlig455_060156 | Neo: - Age: - |
0.954 | - | - | - | - | 0.954 | - | Mlig455_060156 {REF} {Length: 2150} {RNA1509_40399} {RNA1310_86013} {RNA815_53527} | |
97. | MligTC455_12552 | 150 | 3.13 | Mlig455_063669 | Neo: - Age: - |
0.954 | - | - | - | - | - | 0.954 | Mlig455_063669 {REF} {Length: 690} {RNA1509_32639} {RNA1310_46019, RNA1509_32639} {RNA1509_32639, RNA815_20672} | |
98. | MligTC455_12269 | 42 | 0.88 | Mlig455_062448 | Neo: - Age: - Region-enriched R2: 6.351/0.02912 |
0.953 | - | 0.953 | - | - | - | - | Mlig455_062448 {REF} {Length: 941} {RNA1310_43338} {RNA815_24238} | |
99. | MligTC455_02048 | 34 | 0.71 | Mlig455_031731 | Neo: - Age: - |
WDR87 | 0.952 | - | - | - | - | 0.952 | - | Mlig455_031731 {REF} {Length: 1361} {Pfam: Bcl-2 homology region 4 [PF02180.19, score=37.3]; Outer membrane efflux protein [PF02321.20, score=26.8]; Protein of unknown function (DUF745) [PF05335.15, score=19.1]} {Human: ENSG00000171804, WDR87, WD repeat domain 87, [RH, Score=73.9, Expect=2e-15]} |
100. | MligTC455_44800 | 403 | 8.4 | Mlig455_013948, Mlig455_039343 | Neo: - Age: Down-Down-Up Region-enriched R8: 3.937/0.01062 Regeneration-downregulated BL: -8.303 Regeneration-depleted BL: -8.303 |
0.952 | - | - | - | - | 0.952 | - | Mlig455_013948 {REF} {Length: 595} {RNA1509_58184} {RNA1310_30957} {RNA815_17521} Mlig455_039343 {REF} {Length: 595} {RNA1509_58184} {RNA1310_30957, RNA1509_58184} {RNA1509_58184, RNA815_17521} |